Purchases and Sales Made in Q3 2024 in Cardiff Oncology, Inc. (CRDF)
This table provides information about the institutional ownership of Cardiff Oncology, Inc. (CRDF) during Q3 2024. The information is specifically focused on institutions that hold shares of Cardiff Oncology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 12, 2025
Q3 2024
|
Bit Capital Gmb H
Berlin, 2M |
SELL
|
- |
-42.4K- 14.36% |
$87K - $118K
|
253K
$1.2M
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-52.8K- 54.56% |
$108K - $146K
|
44K
$209K
|
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-58.9K- 38.52% |
$121K - $163K
|
94K
$446K
|
|
|
Nov 14, 2024
Q3 2024
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-85.8KClosed |
$176K - $238K
|
0
$0
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-86.9K- 36.28% |
$178K - $241K
|
153K
$725K
|
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-156K- 52.14% |
$319K - $432K
|
143K
$679K
|
|
|
Oct 23, 2024
Q3 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-945K- 77.75% |
$1.94M - $2.62M
|
271K
$1.28M
|